Alfred O. Berg, MD, MPH, Department of Family Medicine, University of Washington, Seattle, WA
Jonine L. Bernstein, PhD, Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY
Lars Bertram, MD, Genetics and Aging Research Unit, MassGeneral Institute for Neurodegenerative Disease (MIND), Charlestown, MA
Nick Birkett, MD, MSc, Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, ON, Canada
Paolo Boffetta, MD, International Agency for Research on Cancer, Lyon, France
Melissa L. Bondy, PhD, Department of Epidemiology, University of Texas, M.D. Anderson Cancer Center, Houston, TX
Linda A. Bradley, PhD, Department of Pathology and Laboratory Medicine, The Warren Alpert Medical School of Brown University, Providence, RI
Molly S. Bray, PhD, Center for Human Genetics, Institute of Molecular Medicine and School of Public Health, University of Texas, Houston, TX
Paul E. Brenchley, PhD, Renal Research Laboratories, Manchester Institute of Nephrology and Transplantation, Royal Infirmary, Manchester, United Kingdom
Philippa Brice, PhD, PHG Foundation, Strangeways Research Laboratory, Cambridge, United Kingdom
Patricia A. Buffler, PhD, MPH, Division of Epidemiology, University of California, Berkeley School of Public Health, Berkeley, CA
Paul R. Burton, MD, Department of Health Sciences, University of Leicester, Leicester, United Kingdom
Adam S. Butterworth, MSc, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom
and UK HuGENet Coordinating Centre, Cambridge, United Kingdom
Ned Calonge, MD, MPH, Colorado Department of Public Health and Environment, Denver, CO
Harry Campbell, MD, FRCP, FFPH, FRSE, Public Health Sciences, College of Medicine and Vet Medicine, University of Edinburgh, Edinburgh, United Kingdom
Juan Pablo Casas, MD, Department of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, United Kingdom
Stephen J. Chanock, MD, Advanced Technology Center, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD
Anand P. Chokkalingam, PhD, MS, Division of Epidemiology, School of Public Health, University of California at Berkeley, Berkeley, CA
Barbara Cohen, PhD, Former Senior Editor, Public Library of Science, San Francisco, CA
John Danesh, MD, MBChB, MSc, DPhil, FRCP, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom
George Davey-Smith, MD, DSc, FFPH, Department of Social Medicine, University of Bristol, Bristol, United Kingdom
Alex Demarsh, MSc, Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, ON, Canada
Siobhan M. Dolan, MD, MPH, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY
W. David Dotson, PhD, Office of Public Health Genomics, Centers for Disease Control and Prevention, Atlanta, GA
Michael P. Douglas, MS, Office of Public Health Genomics, Centers for Disease Control and Prevention, Atlanta, GA
Cornelia van Duijn, PhD, European Journal of Epidemiology, Rotterdam, The Netherlands
Ross Duncan, PhD, MA, Department of Dermatology, Leiden University Medical Center, Leiden, The Netherlands
Shah Ebrahim, MSc, DM, FRCP, FFPHM, London School of Hygiene and Tropical Medicine, London, United Kingdom
Erik von Elm, MD, MSc, Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland
and German Cochrane Centre, Department of Medical Biometry and Medical Informatics, University Medical Centre, Freiburg, Germany
Jonine D. Figueroa, PhD, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Department of Health and Human Services, Bethesda, MD
Isabel Fortier, PhD, Faculty of Law, Université de Montreal, Montréal, QC, Canada
and Genome Quebec & P3G Observatory, McGill University and Genome Quebec Innovation Center, Montréal, QC, Canada
Matthew Freedman, MD, Dana-Farber Cancer Institute, Boston, MA
Helena Furberg, PhD, University of North Carolina at Chapel Hill, Chapel Hill, NC
France Gagnon, MSc, PhD, University of Toronto, Dalla Lana School of Public Health, Toronto, ON, Canada
Montserrat Garcia-Closas, MD, MPH, DrPH, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD
Jean Golding, PhD, DSc, FMedSci, Paediatric and Perinatal Epidemiology, Bristol, United Kingdom
Jesus Gonzalez-Bosquet, MD, PhD, Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD
Jeremy Grimshaw, MBChB, PhD, FRCGP, Canada Research Chair in Health Knowledge Transfer and Uptake
Clinical Epidemiology Program, Ottawa Health Research Institute, Department of Medicine, University of Ottawa, Ottawa, ON, Canada
Scott D. Grosse, PhD, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA
Ira Grossman, PhD, IGSP Center for Population Genomics and Pharmacogenetics, Duke University, Durham, NC
Nelleke A. Gruis, PhD, Harvard School of Public Health, Boston, MA
James M. Gudgeon, MS, MBA, Intermountain Healthcare Clinical Genetics Institute, Salt Lake City, UT
Marta L. Gwinn, MD, MPH, Office of Public Health Genomics, Centers for Disease Control and Prevention, Atlanta, GA
James E. Haddow, MD, Department of Pathology and Laboratory Medicine (Research), The Warren Alpert Medical School of Brown University, Providence, RI
Mia Hashibe, PhD, Gene-Environment Epidemiology Group, International Agency for Research on Cancer, Lyon, France
Steven Hawken, MSc, Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, ON, Canada
David J. Hunter, MBBS, ScD, Program in Molecular and Genetic Epidemiology, Departments of Epidemiology and Nutrition, Harvard School of Public Health, Boston, MA
Kimberley Hutchings, MSc, Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, ON, Canada
Claire Infante-Rivard, MD, PhD, Department of Epidemiology, Biostatistics and Occupational Health, Faculty of Medicine, McGill University, Montréal, QC, Canada
Cecile J.W. Janssens, PhD, Erasmus University Medical Center, Rotterdam, The Netherlands
Marjo-Riitta Jarvelin, MD, MSc, PhD, Department of Epidemiology and Public Health, Imperial College, London, United Kingdom
and Department of Public Health Science and General Practice, University of Oulu, Oulu, Finland
Candice Y. Johnson, MSc, Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, ON, Canada
Richard A. King, MD, Genetics in Medicine, Minneapolis, MN
Bartha Knoppers, LLB, PhD, Faculty of Law, Université de Montreal, Montréal, QC, Canada
Peter Kraft, PhD, Department of Epidemiology and Biostatistics, Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, MA
Beatrice Malmer, MD, PhD, Department of Radiation Sciences, Oncology, Umea University Hospital, Umea, Sweden
Teri Manolio, MD, PhD, Office of Population Genomics, National Human Genome Research Institute, Bethesda, MD
Demetrius M. Maraganore, MD, Department of Neurology, Mayo Clinic, Rochester, MN
Lindsey Masson, PhD, MSc, BSc, RPHNutr, Department of Public Health, University of Aberdeen, Aberdeen, Scotland, United Kingdom
David B. Matchar, MD, Duke Center for Clinical Health Policy Research, Durham, NC
and Department of Veterans Affairs Medical Center, Durham, NC
and Duke-NUS Graduate Medical School Program in Health Services Research, Singapore
Colleen M. McBride, PhD, Social and Behavioral Research Branch, National Human Genome Research Institute, Washington, DC
Mark McCarthy, MB, BChir, PhD, FRCP, Research Department of Epidemiology and Public Health, University College London, London, United Kingdom
Monica R. McClain, PhD, Division of Medical Screening, Women & Infants Hospital, Providence, RI
John McLaughlin, PhD, Population Studies and Surveillance, Cancer Care Ontario, Toronto, ON, Canada
and Prosserman Centre for Health Research at the Samuel Lunenfeld Research Institute, Toronto, ON, Canada
Joyce B.J. van Meurs, PhD, Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands
David Moher, PhD, Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, ON, Canada
Julia A. Newton-Bishop, PhD, Genetic Epidemiology Division, CR-UK Clinical Centre, Leeds, United Kingdom
Thomas R. O'Brien, MD, MPH, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD
James M. Ostell, PhD, Information Engineering Branch, National Center for Biotechnology Information, National Library of Medicine, NIH, Bethesda, MD
Ryan P. Owen, PhD, PharmGKB, Genetics Department, Stanford University, Stanford, CA
Roberta A. Pagon, MD, University of Washington School of Medicine, Seattle, WA
Glenn E. Palomaki, BS, Department of Pathology and Laboratory Medicine, The Warren Alpert Medical School of Brown University, Providence, RI
Andrew Paterson, MD, Genetics of Complex Diseases, Hospital for Sick Children (SickKids), Toronto, ON, Canada
Diana B. Petitti, MD, MPH, Department of Biomedical Informatics, Arizona State University, Phoenix AZ
Margaret Piper, PhD, Genomics Resources, Technology Evaluation Center, Blue Cross Blue Shield Association, Atlanta, GA
Timothy R. Rebbeck, PhD, Center for Clinical Epidemiology and Biostatistics, School of Medicine, University of Pennsylvania, Philadelphia, PA
Elio Riboli, PhD, International Agency for Research on Cancer, Lyon, France
and Imperial College, London, United Kingdom
Fernando Rivadeneira, MD, PhD, Departments of Internal Medicine and Epidemiology & Biostatistic, Erasmus MC, Rotterdam, The Netherlands
Nathaniel Rothman, MD, MPH, MHS, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD
Georgia Salanti, PhD, School of Medicine and Biomedical Research Institute, University of Ioannina, Ioannina, Greece
Nadeem Sarwar, MPhil, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom
Saskia C. Sanderson, PhD, Social and Behavioral Research Branch, National Human Genome Research Institute, Washington, DC
Paul Scheet, PhD, MD Anderson Cancer Center, Department of Epidemiology, University of Texas, Houston, TX
Daniela Seminara, PhD, MPH, Epidemiology and Genetics Research Branch, Division of Cancer Control and Population Sciences, National Cancer Institute, NIH, Bethesda, MD
Linda Sharp, PhD, National Cancer Registry (NCR), Cork, Ireland, United Kingdom
M. Alexandre Stewart, PhD, BScH, MSc, University of Ottawa Heart Institute, Ottawa, ON, Canada
Emanuela Taioli, MD, PhD, University of Pittsburgh Cancer Institute, University of Pittsburgh Medical Center, Pittsburgh, PA
Valerie Tait, PhD, Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, ON, Canada
Steven M. Teutsch, MD, MPH, Outcomes Research and Management, Merck & Company, Inc., West Point, PA
Mugdha Thakur, MD, Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC
Evropi Theodoratou, PhD, Public Health Sciences, University of Edinburgh, Edinburgh, Scotland, United Kingdom
Duncan C. Thomas, PhD, Biostatistics Division, Department of Preventive Medicine, University of Southern California, Los Angeles, CA
Nic Timpson, PhD, Department of Social Medicine, University of Bristol, Bristol, United Kingdom
André G. Uitterlinden, MD, PhD, Departments of Internal Medicine and Epidemiology & Biostatistics, Erasmus MC, Rotterdam, The Netherlands
Rodolfo Valdez, PhD, MSc, Office of Public Health Genomics, Centers for Disease Control and Prevention, Atlanta, GA
David L. Veenstra, PhD, PharmD, Pharmaceutical Outcomes Research and Policy Program and Institute for Public Health Genetics, University of Washington, Seattle, WA
Mukesh Verma, PhD, Methods and Technologies Branch, Epidemiology and Genetics Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD
Paolo Vineis, MD, MPH, Environmental Epidemiology, Imperial College, London, United Kingdom
Christopher Wade, PhD, Social and Behavioral Research Branch, National Human Genome Research Institute, Washington, DC
Nick Wareham, PhD, MRC, Medical Research Council Epidemiology Unit, Elsie Widdowson Laboratories, Cambridge, United Kingdom
George Wells, MSc, PhD, Cardiovascular Research Methods Centre, University of Ottawa Heart Institute, Ottawa, ON, Canada
Miriam Wiens, BSc MSc, Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, ON, Canada
Marc S. Williams, MD, Intermountain Healthcare Clinical Genetics Institute, Salt Lake City, UT
Robin E. Williamson, PhD, American Journal of Human Genetics, Boston, MA
Deborah M. Winn, PhD, Clinical and Genetic Epidemiology Research Branch, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD
Paula W. Yoon, ScD, MPH, Division for Heart Disease and Stroke Prevention, Centers for Disease Control and Prevention, Atlanta, GA
Wei Yu, PhD, MS, Office of Public Health Genomics, Centers for Disease Control and Prevention, Atlanta, GA
Maja Zecevic, PhD, MPH, Lancet, New York, NY
Eleftheria Zeggini, PhD, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom
Ron Zimmern, MA, FRCP, FFPHM, PHG Foundation, Strangeways Research Laboratory, Cambridge, United Kingdom
Guang Yong Zou, PhD, Department of Epidemiology and Biostatistics, University of Western Ontario, London, ON, Canada
and
Robarts Clinical Trials, Robarts Research Institute, London, ON, Canada
